arrow
P

Pyone P. Aye

Tulane University
H指数:29
被引数:3,496

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CXCR4-tropic HIV-1 infection in an immunocompetent monkey model

CXCR4嗜性HIV-1感染在免疫健全的猴模型中

2026-03-090
OAAI
The Impact of SIV-Induced Immunodeficiency on SARS-CoV-2 Disease, Viral Dynamics, and Antiviral Immune Response in a Nonhuman Primate Model of Coinfection
2024-07-210
OAAI
Cytomegalovirus vaccine vector-induced effector memory CD4+T cells protect cynomolgus macaques from lethal aerosolized heterologous avian influenza challenge
2024-07-190
OAAI
A combined adjuvant approach primes robust germinal center responses and humoral immunity in non-human primates
2023-11-044
OAAI
Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIVmac251 acquisition in macaques
2023-04-212
OAAI
Author Correction: Long-primed germinal centres with enduring affinity maturation and clonal migration

作者更正:具有持久亲和力成熟和克隆迁移的长期预激活生发中心

Nature
IF48.5
2023-01-300
PRE
Recombinant Simian Varicella Virus-Simian Immunodeficiency Virus Vaccine Induces T and B Cell Functions and Provides Partial Protection against Repeated Mucosal SIV Challenges in Rhesus Macaques

重组猿猴水痘病毒-猿猴免疫缺陷病毒疫苗可诱导T和b细胞功能,并对恒河猴的反复粘膜SIV攻击提供部分保护

2022-12-173
OAAI
Long-primed germinal centres with enduring affinity maturation and clonal migration

具有持久亲和力成熟和克隆迁移的长引物生发中心

Nature
IF48.5
2022-09-210
PRE
Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine

佐剂亚单位疫苗可诱导对SARS-CoV-2 Omicron变体的持久保护

2022-08-1733
OA
A cellular trafficking signal in the SIV envelope protein cytoplasmic domain is strongly selected for in pathogenic infection
2022-06-174
OAAI
Development of an In Vivo Probe to Track SARS-CoV-2 Infection in Rhesus Macaques
2021-12-242
OAAI
The pigtail macaque (Macaca nemestrina) model of COVID-19 reproduces diverse clinical outcomes and reveals new and complex signatures of disease
2021-12-209
OAAI
Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge
2020-05-0142
OAAI